Sign Up to like & get
recommendations!
0
Published in 2021 at "Human Genetics"
DOI: 10.1007/s00439-021-02289-w
Abstract: Dyslexia is a common heritable developmental disorder involving impaired reading abilities. Its genetic underpinnings are thought to be complex and heterogeneous, involving common and rare genetic variation. Multigenerational families segregating apparent monogenic forms of language-related…
read more here.
Keywords:
sema3c;
variation;
whole genome;
noncoding variation ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Kidney international"
DOI: 10.1016/j.kint.2021.12.028
Abstract: To guide the development of therapeutic interventions for acute kidney injury, elucidating the deleterious pathways of this global health problem is highly warranted. Emerging evidence has indicated a pivotal role of endothelial dysfunction in the…
read more here.
Keywords:
semaphorin;
kidney injury;
acute kidney;
injury ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Diabetes"
DOI: 10.2337/db18-1172
Abstract: The diabetic cornea exhibits pathological alterations, such as delayed epithelial wound healing and nerve regeneration. We investigated the role of semaphorin (SEMA) 3C in corneal wound healing and reinnervation in normal and diabetic B6 mice.…
read more here.
Keywords:
sensory nerve;
sema3c;
regeneration;
role ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2019.01035
Abstract: Introduction: Aberrant activation of Semaphorin3C(SEMA3C) is widespread in human cancers. We aimed to analyze SEMA3C expression in cervical cancer and investigate the role of SEMA3C in cervical cancer and its underlying mechanism, which is important…
read more here.
Keywords:
sema3c;
poor prognosis;
associated poor;
cervical cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.890154
Abstract: To date, driver genes for pancreatic cancer treatment are difficult to pursue therapeutically. Targeting mutated KRAS, the most renowned driver gene in pancreatic cancer, is an active area of study. We discovered a gene named…
read more here.
Keywords:
inhibition;
sema3c;
pancreatic cancer;
tumor immune ... See more keywords